-
Mashup Score: 0Adding Pembrolizumab to Platinum and Pemetrexed Improves OS in Treatment-Naive MPM - ILCN.org (ILCN/WCLC) - 9 month(s) ago
Dr. Quincy Chu recently shared results from the phase III IND227 trial, which also demonstrated improved progression-free survival in mesothelioma patients who received the combination compared to those who received standard chemotherapy alone.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Artificial Intelligence in Healthcare: A Patient Perspective - ILCN.org (ILCN/WCLC) - 10 month(s) ago
When life-and-death decisions are at stake, will patients welcome AI to their care team? As part of ILCN’s series on AI in lung cancer, patient advocate Angus Pratt explores issues of trust, safety, accuracy, and more.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
While exploring AI use in healthcare, we must not cede our humanity and autonomy, says patient advocate @anguspratt Read more in #ILCN: https://t.co/IXauDj13AO #LCSM https://t.co/YvPSmpl0je
-
-
Mashup Score: 0Demystifying AI: Current Insights on Artificial Intelligence in Thoracic Oncology - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Dr. Raymond Mak and Fridolin Haugg delve into the artificial intelligence discussion with an overview of AI basics and a look at how AI is already influencing the lung cancer field.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How is artificial intelligence already influencing the #lungcancer field? @dr_raymak and Fridolin Haugg share insights in #ILCN: https://t.co/XIT7FuuJGU #LCSM https://t.co/wRqadX4iL8
-
-
Mashup Score: 0In Brief for June 28, 2023 - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Canada to require health warnings on cigarettes. US FDA approves application for pemetrexed injection, grants priority review for repotrectinib.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Catch up on recent announcements in #ILCN, including a new requirement for health warnings on cigarettes in Canada: https://t.co/wILG650GwI #LCSM
-
-
Mashup Score: 1IASLC Announces Results of 2023 Board of Directors Election - ILCN.org (ILCN/WCLC) - 10 month(s) ago
The newly elected board members, including President-Elect Dr. Caicun Zhou, will assume their roles at the upcoming 2023 World Conference on Lung Cancer in Singapore.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Meet the newly elected IASLC board members who will begin their terms at #WCLC23, including President-Elect Caicun Zhou, MD, PhD. Learn more in #ILCN: https://t.co/hDDPkz5Zou #LCSM
-
-
Mashup Score: 0International Group Consensus Statement Offers Technical Guidance for MPM Imaging - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Dr. Sharyn Katz and colleagues summarize key recommendations for improving imaging quality in malignant pleural mesothelioma.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New in #ILCN: A look at recently published recommendations for improving imaging quality in malignant pleural mesothelioma. https://t.co/rbUisr4VxK #LCSM
-
-
Mashup Score: 3Tumor Treating Fields May Provide Additional Treatment Option for mNSCLC Following Progression - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Investigator Ticiana Leal, MD, said the the phase III LUNAR study met its primary endpoint and demonstrated a statistically significant 3-month improvement in median overall survival versus the standard of care.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Recap from #ASCO23: @LealTiciana presented findings on TTFields therapy with standard of care for mNSCLC after platinum-based therapy. Read more in #ILCN: https://t.co/Vydf6c4GhS #LCSM
-
-
Mashup Score: 0From the Editors: Those in Thoracic Oncology Field Must Educate Themselves About Artificial Intelligence - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Like it or not, AI will be part the diagnostic and therapeutic landscape, and it is incumbent on clinicians to understand its implications, limitations, and benefits, ILCN editors say.
Source: ILCN.org (ILCN/WCLC)Categories: Latest Headlines, Oncologists2Tweet-
From the Editors: Those in Thoracic Oncology Field Must Educate Themselves About Artificial Intelligence https://t.co/krZ30mbkO0
-
-
Mashup Score: 0From the Editors: Those in Thoracic Oncology Field Must Educate Themselves About Artificial Intelligence - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Like it or not, AI will be part the diagnostic and therapeutic landscape, and it is incumbent on clinicians to understand its implications, limitations, and benefits, ILCN editors say.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
From the editors of #ILCN: "Like it or not, AI will be an intrinsic component of the diagnostic and therapeutic landscape." https://t.co/iz3iZYMIuY @maryjofidlerMD #LCSM
-
-
Mashup Score: 4From the Editors: Defining Resectability of Non-Small Cell Lung Cancer in 2023 - ILCN.org (ILCN/WCLC) - 10 month(s) ago
Is “resectability” based on radical resection criteria still valid in the era of neoadjuvant immunochemotherapy? ILCN’s editors say the term needs to be revisited and probably redefined based on a tumor’s status before treatment and after neoadjuvant treatment.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Oncs, Latest HeadlinesTweet-
What is the most timely topic in thoracic oncology? ‘Is it time to redefine “resectability” in the era of neoadjuvant chemo-IO?’ in #ILCN Catch these topics & more @IASLC #WCLC23 in Singapore. Register today https://t.co/3pLP2WAHzP @HegiFiona @HwakeleeMD @karenkellymd #LCSM
-
During #ASCO23, Dr. Quincy Chu presented results from the phase III IND227 trial of malignant pleural mesothelioma treatment options. Read a recap in #ILCN: https://t.co/EBchlaHVan #LCSM https://t.co/a0RZIXvHUm